Access to innovation through the French Expanded-Access Program and clinical trials in patients with malignant melanoma.

被引：0
|
作者：
Christen, Claire
Belgodere, Laetitia
Guillot, Bernard
Kerouani-Lafaye, Ghania
Brunel, Liora
Turcry, Florence
Monard, Adrien
Grude, Francoise
Guyader, Gaelle
Boudali, Lotfi
Albin, Nicolas
机构：
[1] French Natl Agcy Med & Hlth Prod Safety ANSM, St Denis, France
[2] CHU Montpellier, Univ Hosp Montpellier, Dermatol Dept, Montpellier, France
[3] Grp Hosp Mutualiste Grenoble, Grenoble, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e22030
引用
收藏
页数：2
相关论文
共 50 条
  • [31] REACT expanded-access program in patients with metastatic renal cell carcinoma: real-world data from a European subanalysis
    Bracarda, Sergio
    Rottey, Sylvie
    Bahl, Amit
    Eichelberg, Christian
    Mellado, Begona
    Mangel, Laszlo
    Cattaneo, Agnese
    Panneerselvam, Ashok
    Gruenwald, Viktor
    FUTURE ONCOLOGY, 2015, 11 (21) : 2893 - 2903
  • [32] Characteristics of the Compassionate Use Program in Japan: An Analysis of Expanded Access Clinical Trials from 2016 to 2021
    Maeda, Hideki
    Uchida, Marika
    Kusano, Mikiko
    Tsukamoto, Katsura
    Yamanoi, Moeka
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (04) : 817 - 823
  • [33] Safety and efficacy of Ruxolitinib in expanded-access JUMP study: an update from a cohort of 1869 patients
    Al-Ali, H. K.
    Tavares, R.
    Palumbo, G. A.
    Palandri, F.
    Martino, B.
    Liberati, A. M.
    Ullrich, J. G.
    Breccia, M.
    Brittain, D.
    Foltz, L.
    Griesshammer, M.
    Raanani, P.
    Gupta, V
    Giraldo, P.
    Ghosh, J.
    Tannir, B.
    Ronco, J. P.
    Vannucchi, A. M.
    Le Coutre, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 233 - 233
  • [34] An expanded-access clinical study of thiotepa (DSP-1958) high-dose chemotherapy before autologous hematopoietic stem cell transplantation in patients with malignant lymphoma
    Nishikori, Momoko
    Masaki, Yasufumi
    Fujii, Nobuharu
    Ikeda, Takashi
    Takahara-Matsubara, Mariko
    Sugimoto, Saori
    Kondo, Eisei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (03) : 391 - 398
  • [35] Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program
    Hayley Gans
    Roy F. Chemaly
    BMC Infectious Diseases, 21
  • [36] Ipilimumab for advanced, refractory melanoma: A report of the Israeli cohort of expanded access program
    Shapira-Frommer, Ronnie
    Stephen, Frank
    Ben-Ami, Eytan
    Hamburger, Tamar
    Markel, Gal
    Ospovat, Inna
    Zippel, Douglas
    Merims, Sharon
    Apter, Sara
    Steinberg, Hani
    Silman-Steiberg, Yael
    Peretz, Tamar
    Lotem, Michal
    Schachter, Jacob
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy)
    Anna Maria Di Giacomo
    Riccardo Danielli
    Luana Calabrò
    Erica Bertocci
    Chiara Nannicini
    Diana Giannarelli
    Angelo Balestrazzi
    Francesco Vigni
    Valentina Riversi
    Clelia Miracco
    Maurizio Biagioli
    Maresa Altomonte
    Michele Maio
    Cancer Immunology, Immunotherapy, 2011, 60 : 467 - 477
  • [38] Long-term Survival with Ipilimumab: Experience from a National Expanded Access Program for Patients with Melanoma
    Krajsova, Ivana
    Arenberger, Petr
    Lakomy, Radek
    Kubala, Eugen
    Brezinova, Ivana
    Poprach, Alexandr
    Stastny, Marek
    Muzik, Jan
    Melichar, Bohuslav
    ANTICANCER RESEARCH, 2015, 35 (11) : 6303 - 6310
  • [39] Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile
    Del Vecchio, M.
    Di Giacomo, A. M.
    Quaglino, P.
    Sileni, V. Chiarion
    Queirolo, P.
    De Galitiis, F.
    Cognetti, F.
    Mandala', M.
    Guidoboni, M.
    Rinaldi, G.
    Depenni, R.
    Consoli, F.
    Troiani, T.
    Guida, M.
    Marconcini, R.
    Ferrucci, P. F.
    Bersanelli, M.
    Rossi, E.
    Aglietta, M.
    Ascierto, P. A.
    ANNALS OF ONCOLOGY, 2021, 32 : S890 - S891
  • [40] Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy)
    Di Giacomo, Anna Maria
    Danielli, Riccardo
    Calabro, Luana
    Bertocci, Erica
    Nannicini, Chiara
    Giannarelli, Diana
    Balestrazzi, Angelo
    Vigni, Francesco
    Riversi, Valentina
    Miracco, Clelia
    Biagioli, Maurizio
    Altomonte, Maresa
    Maio, Michele
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (04) : 467 - 477
12345